Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial

References

• Association AP. Diagnostic criteria from dsM-iV-tr. American Psychiatric Pub; 2000.
   Google Scholar
• Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012;9(3):490–9. doi: 10.1007/s13311-012-0135-8
   PubMed Web of Science ®Google Scholar
• Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry 2014;53(1):34–46.e2. doi: 10.1016/j.jaac.2013.09.001
   PubMed Web of Science ®Google Scholar
• Alavi A, Mohammadi MR, Joshaghani N, Mahmoudi-Gharaei J. Frequency of psychological disorders amongst children in urban areas of Tehran. Iran J Psychiatry 2010;5(2):55–9.
   PubMedGoogle Scholar
• Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006;36(2):167–79. doi: 10.1017/S0033291705006410
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Monuteaux MC, Fried R, Byrne D, Mirto T, et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry 2010;167(4):409–17. doi: 10.1176/appi.ajp.2009.09050736
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006;36(2):159–65. doi: 10.1017/S003329170500471X
   PubMed Web of Science ®Google Scholar
• Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, et al. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry 2012;51(10):990–1002.e2. doi: 10.1016/j.jaac.2012.07.008
   PubMed Web of Science ®Google Scholar
• Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 2014;48(2):209–25. doi: 10.1177/1060028013510699
   PubMed Web of Science ®Google Scholar
• Arnsten AFT, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 2005;1(1):2. doi: 10.1186/1744-9081-1-2
   PubMed Web of Science ®Google Scholar
• Lee J, Grizenko N, Bhat V, Sengupta S, Polotskaia A, Joober R. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry 2011;11:70. doi: 10.1186/1471-244X-11-70
   Web of Science ®Google Scholar
• Mick E, McManus DD, Goldberg RJ. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. Eur Neuropsychopharmacol 2013;23(6):534–41. doi: 10.1016/j.euroneuro.2012.06.011
   PubMed Web of Science ®Google Scholar
• Cortese S. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol 2012;16(5):422–33. doi: 10.1016/j.ejpn.2012.01.009
   PubMed Web of Science ®Google Scholar
• Slavov GS, Trenova AG, Manova MG, Kostadinova, II, Vasileva TV, Zahariev ZI. Vitamin D immunomodulatory potential in multiple sclerosis. Folia Med (Plovdiv) 2013;55(2):5–9.
   PubMedGoogle Scholar
• Tagliabue E, Raimondi S, Gandini S. Vitamin D, Cancer Risk, and Mortality. Adv Food Nutr Res 2015;75:1–52. doi: 10.1016/bs.afnr.2015.06.003
   PubMedGoogle Scholar
• Wang TJ. Vitamin D and cardiovascular disease. Annu Rev Med 2016;67:261–72. doi: 10.1146/annurev-med-051214-025146
   PubMed Web of Science ®Google Scholar
• Bener A, Khattab AO, Al-Dabbagh MM. Is high prevalence of Vitamin D deficiency evidence for autism disorder?: In a highly endogamous population. J Pediatr Neurosci 2014;9(3):227–33. doi: 10.4103/1817-1745.147574
   PubMedGoogle Scholar
• Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health 2016;19(1):6–9. doi: 10.1136/eb-2015-102117
   PubMed Web of Science ®Google Scholar
• Józefowicz O, Rabe-Jabłońska J, Woźniacka A, Strzelecki D. Analysis of vitamin D status in major depression. J Psychiatr Pract 2014;20(5):329–37. doi: 10.1097/01.pra.0000454777.21810.15
   PubMed Web of Science ®Google Scholar
• Meyer T, Becker A, Sundermann J, Rothenberger A, Herrmann-Lingen C. Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Eur Child Adolesc Psychiatry 2016.
   Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat 2005;29(1):21–30. doi: 10.1016/j.jchemneu.2004.08.006
   PubMed Web of Science ®Google Scholar
• Cui X, Pelekanos M, Liu P-Y, Burne THJ, McGrath JJ, Eyles DW. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 2013;236:77–87. doi: 10.1016/j.neuroscience.2013.01.035
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Sakiyama R, Coty WA. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 1985;44(4):1138–41. doi: 10.1111/j.1471-4159.1985.tb08735.x
   PubMed Web of Science ®Google Scholar
• Kamal M, Bener A, Ehlayel MS. Is high prevalence of vitamin D deficiency a correlate for attention deficit hyperactivity disorder? Atten Defic Hyperact Disord 2014;6(2):73–8. doi: 10.1007/s12402-014-0130-5
   PubMedGoogle Scholar
• Sharif MR, Madani M, Tabatabaei F, Tabatabaee Z. The relationship between serum vitamin D Level and attention deficit hyperactivity disorder. Iran J Child Neurol 2015;9(4):48–53.
   PubMed Web of Science ®Google Scholar
• Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr 2012;15(2):324–30. doi: 10.1017/S1368980011000188
   PubMed Web of Science ®Google Scholar
• Conners CK, Multi-Health System I. Conners’ parent rating scale – revised (s). North Tonawanda (NY): Multi-Health Systems; 1997.
   Google Scholar
• DuPaul GJ. ADHD Rating Scale-IV: checklists, norms, and clinical interpretation. New York: Guilford Press; 1998.
   Google Scholar
• Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002;159(11):1896–901. doi: 10.1176/appi.ajp.159.11.1896
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CM. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement. Prog Neuropsychopharmacol Biol Psychiatry 2014;50:163–71. doi: 10.1016/j.pnpbp.2013.12.014
   PubMed Web of Science ®Google Scholar
• Shang-Guan LL, Zhao YR. [Serum levels of 25-hydroxyvitamin D in children with attention deficit hyperactivity disorder]. Zhongguo Dang Dai Er Ke Za Zhi 2015;17(8):837–40.
   PubMedGoogle Scholar
• Morales E, Julvez J, Torrent M, Ballester F, Rodriguez-Bernal CL, Andiarena A, et al. Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood. Epidemiology 2015;26(4):458–65. doi: 10.1097/EDE.0000000000000292
   PubMed Web of Science ®Google Scholar
• Strøm M, Halldorsson TI, Hansen S, Granström C, Maslova E, Petersen SB, et al. Vitamin D measured in maternal serum and offspring neurodevelopmental outcomes: a prospective study with long-term follow-up. Ann Nutr Metab 2014;64(3–4):254–61. doi: 10.1159/000365030
   PubMed Web of Science ®Google Scholar
• Ubbenhorst A, Striebich S, Lang F, Lang UE. Exploring the relationship between vitamin D and basic personality traits. Psychopharmacology (Berl) 2011;215(4):733–7. doi: 10.1007/s00213-011-2175-x
   PubMed Web of Science ®Google Scholar
• Tolppanen A-M, Sayers A, Fraser WD, Lewis G, Zammit S, Lawlor DA. The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood. PLoS One 2012;7(7):e40097. doi: 10.1371/journal.pone.0040097
   PubMed Web of Science ®Google Scholar
• Burne THJ, Becker A, Brown J, Eyles DW, Mackay-Sim A, McGrath JJ. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav Brain Res 2004;154(2):549–55. doi: 10.1016/j.bbr.2004.03.023
   PubMed Web of Science ®Google Scholar
• Byrne JH, Voogt M, Turner KM, Eyles DW, McGrath JJ, Burne TH. The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats. PLoS One 2013;8(8):e71593. doi: 10.1371/journal.pone.0071593
   PubMed Web of Science ®Google Scholar
• Vazquez G, de Boland AR, Boland RL. Involvement of calmodulin in 1alpha ,25-dihydroxyvitamin D3 stimulation of store-operated Ca2+ influx in skeletal muscle cells. J Biol Chem 2000;275(21):16134–8. doi: 10.1074/jbc.C901008199
   PubMed Web of Science ®Google Scholar
• Sepehrmanesh Z, Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi Z, et al. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J Nutr 2016;146(2):243–8. doi: 10.3945/jn.115.218883
   PubMed Web of Science ®Google Scholar
• Cui X, Pertile R, Liu P, Eyles DW. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience 2015;304:90–100. doi: 10.1016/j.neuroscience.2015.07.048
   PubMed Web of Science ®Google Scholar
• Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS One 2013;8(4):e62040. doi: 10.1371/journal.pone.0062040
   PubMed Web of Science ®Google Scholar
• Tekes K, Gyenge M, Folyovich A, Csaba G. Influence of neonatal vitamin A or vitamin D treatment on the concentration of biogenic amines and their metabolites in the adult rat brain. Horm Metab Res 2009;41(4):277–80. doi: 10.1055/s-0028-1103287
   PubMed Web of Science ®Google Scholar
• Jiang P, Zhang L-H, Cai H-L, Li H-D, Liu Y-P, Tang M-M, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients 2014;6(12):6048–59. doi: 10.3390/nu6126048
   PubMed Web of Science ®Google Scholar
• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 2013;138(2):155–75. doi: 10.1016/j.pharmthera.2013.01.004
   PubMed Web of Science ®Google Scholar
• Faraone SV, Bonvicini C, Scassellati C. Biomarkers in the diagnosis of ADHD – promising directions. Curr Psychiatry Rep 2014;16(11):497. doi: 10.1007/s11920-014-0497-1
   PubMed Web of Science ®Google Scholar
• Taurines R, Grünblatt E, Schecklmann M, Schwenck C, Albantakis L, Reefschläger L, et al. Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder. World J Biol Psychiatry 2011;12 Suppl. 1:104–8. doi: 10.3109/15622975.2011.600297
   PubMed Web of Science ®Google Scholar
• Peeyush KT, Savitha B, Sherin A, Anju TR, Jes P, Paulose CS. Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation. Pharmacol Biochem Behav 2010;95(2):216–22. doi: 10.1016/j.pbb.2010.01.008
   PubMed Web of Science ®Google Scholar
• Kesby JP, Cui X, O'Loan J, McGrath JJ, Burne THJ, Eyles DW. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology (Berl) 2010;208(1):159–68. doi: 10.1007/s00213-009-1717-y
   PubMed Web of Science ®Google Scholar
• Dhawan P, Christakos S. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: Cooperative effects of the glucocorticoid receptor, C/EBPβ, and the Vitamin D receptor in 24(OH)ase transcription. J Cell Biochem 2010;110(6):1314–23. doi: 10.1002/jcb.22645
   PubMed Web of Science ®Google Scholar